Vivani medical director Williams buys $1.98 million in VANI stock

Director Gregg Williams of Vivani Medical (NASDAQ:VANI), a company currently valued at $78.2 million, recently purchased a total of 1,737,764 shares of common stock in two separate transactions. The purchases, both marked with transaction code "P", involved acquiring shares at prices ranging from $1.12 to $1.26, below the current trading price of $1.32. According to InvestingPro data, the stock has gained over 25% in the past six months, despite showing high volatility with a beta of 3.28.

Specifically, Williams acquired 1,473,214 shares at $1.12 per share, for a total value of $1,649,999. Additionally, he purchased 264,550 shares at $1.26 per share, amounting to $333,333. These insider purchases come as analysts set a bullish target price of $4.00 for the stock, though InvestingPro analysis indicates the company’s overall financial health score remains weak.

Following these transactions, Williams directly owns 4,799,200 shares and indirectly owns 17,647,112 shares. Want deeper insights into insider trading patterns and 7 additional key ProTips for VANI? Discover more with InvestingPro.

In other recent news, Vivani Medical, Inc. announced a delay in the record date for its planned spin-off of Cortigent, Inc. due to the ongoing U.S. federal government shutdown. The company is working to establish a new date as soon as possible. In addition, Vivani Medical has secured $10 million in equity financing to advance the development of its semaglutide implant, NPM-139. This funding is expected to support the company’s financial needs into the second half of 2026.

Vivani has also revealed plans to initiate a Phase 1 clinical trial for the NPM-139 implant in the first half of 2026, pending regulatory clearance. This trial will focus on chronic weight management for patients who are obese or overweight with related health conditions. Furthermore, H.C. Wainwright has maintained a Buy rating on Vivani Medical, with a price target of $4.00, following the announcement of these development plans. These developments mark significant steps for Vivani Medical in its ongoing projects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.